Methyl-Readers and Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 339
Gianluca Sbardella
Altered Long Non-coding RNA Expression in Cancer:
Potential Biomarkers and Therapeutic Targets? . . . . . . . . . . . . . . . . . . . 401
David Hanly, Manel Esteller, and María Berdasco
Acetylation and Methylation in Asthma, COPD, and Lung Cancer . . . . 429
Martijn R. H. Zwinderman, Fangyuan Cao, and Frank J. Dekker
Structure-Based Design of Epigenetic Inhibitors . . . . . . . . . . . . . . . . . . . 455
Dina Robaa, Jelena Melesina, Chiara Luise, and Wolfgang Sippl
Experimental Methodologies for Detection and Mapping
of Epigenetic DNA Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 487
Christopher L. Seiler, Jenna Fernandez, Qiyuan Han,
and Natalia Y. Tretyakova
Advanced Assays in Epigenetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 523
Carmela Dell’Aversana, Federica Sarno, Mariarosaria Conte,
Cristina Giorgio, and Lucia Altucci
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 561
viii
Contents